Medindia

X

Arimidex Works Better In Combination With Herceptin

by Medindia Content Team on  December 15, 2006 at 7:14 PM Drug News   - G J E 4
Arimidex Works Better In Combination With Herceptin
The AstraZeneca (AZN) Phase III Arimidex study began in 2001 and proceeded to evaluate 208 postmenopausal women in 22 countries. The results were presented on Thursday at the 2006 San Antonio Breast Cancer Symposium (SABCS), in North America.
Advertisement

The study reports, postmenopausal women with advanced breast cancer, who received Astrazeneca PLC's ARIMIDEX (anastrozole) in combination with Genentech Inc's Herceptin (trastuzumab) showed a significant improvement in progression-free survival.

Advertisement
The results of the study indicate that the drug ARIMIDEX, in combination with Herceptin, improves the efficacy of breast cancer treatment.

The organizers reported that the overall median survival for patients receiving ARIMIDEX with Herceptin was 28.5 months which is an extended median progression-free survival of 4.8 months, 2.4 months longer than those receiving Arimidex alone.

Source: Medindia
PRI/S
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All